MedTrace Logo

Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization

NCT00187278 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1833

Last updated 2021-01-25

Study results available
· View outcomes & findings →

Summary

The primary purpose of the study is to evaluate if patients with a standard indication for permanent ventricular pacing, left ventricular ejection fraction without limit, or any QRS duration will profit from the prevention of ventricular desynchronisation.

Conditions

  • Atrioventricular Block
  • Ventricular Dysfunction

Interventions

DEVICE

Biventricular Pacing

Biventricular Pacemaker implant

DEVICE

RV Pacing

Standard Pacemaker implant

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Reinhard Funck, MD · Klinikum Bad Hersfeld, Germany

  • Jean-Jacques Blanc, Prof. · Hôpital Cavale Blanche, Brest, France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2014-05-31
Completion
2014-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00187278 on ClinicalTrials.gov